← All trials
NCT01838850
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2013
- Primary completion
- Aug 1, 2014
- Completion date
- Aug 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 344
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Daiichi SankyoLead sponsor
- Inje UniversityOverall official - principal investigator
- Hanyang UniversityOverall official - principal investigator
- Korea UniversityOverall official - principal investigator
- Seoul Veterans HospitalOverall official - principal investigator
- Chonnam National UniversityOverall official - principal investigator
- Konkuk UniversityOverall official - principal investigator
- Yonsei UniversityOverall official - principal investigator
- Chungnam National UniversityOverall official - principal investigator
- Daegu Catholic UniversityOverall official - principal investigator
- Sungkyunkwan UniversityOverall official - principal investigator
- Seoul National UniversityOverall official - principal investigator
- Daedong HospitalOverall official - principal investigator
- Catholic University of KoreaOverall official - principal investigator
- Dong-A UniversityOverall official - principal investigator
- Eulji UniversityOverall official - principal investigator
- Konyang UniversityOverall official - principal investigator
- Kyung Hee UniversityOverall official - principal investigator
- Gachon UniversityOverall official - principal investigator
- Ajou UniversityOverall official - principal investigator
- Chonbuk National UniversityOverall official - principal investigator
- Ilsan HospitalOverall official - principal investigator
- Seoul National UniversityStudy chair
- University of UlsanOverall official - principal investigator
- Hallym UniversityOverall official - principal investigator
- Keimyung UniversityOverall official - principal investigator
- Soonchunhyang UniversityOverall official - principal investigator
- Wonju Christian HospitalOverall official - principal investigator
- Chung-Ang UniversityOverall official - principal investigator
- Pusan National UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.